VOGLIBITE M 0.3 MG TAB
Rs 97.4 10 % Off
Package size
Estimate Delivery by:
Delivering to
Easy 7 days return available
VOGLIBITE M 0.3 MG TAB
Voglibite M 0.3 mg Tablets are specifically formulated to manage symptoms associated with vestibular disorders, including Meniere's disease. Each tablet contains 0.3 mg of Betahistine dihydrochloride, a medication that works by improving blood circulation to the inner ear. This helps alleviate symptoms such as dizziness, vertigo, and tinnitus by stabilizing inner ear pressure and enhancing inner ear function. The tablets are designed for easy ingestion, ensuring accurate dosing and convenience for daily use. With a pack of 10 tablets, Voglibite M offers a practical solution for both short-term symptom relief and long-term management. By addressing the underlying causes of vestibular symptoms, Voglibite M helps improve overall quality of life for individuals experiencing these inner ear conditions.
Product Highlights and Usage:
Active Ingredient: Contains 0.3 mg of Betahistine dihydrochloride, aimed at managing symptoms of vestibular disorders and Meniere's disease. Effective Symptom Relief: Helps reduce dizziness, vertigo, and tinnitus commonly associated with inner ear conditions. Improves Inner Ear Circulation: Enhances blood flow to the inner ear, which helps stabilize symptoms by addressing inner ear pressure and function. Convenient Tablet Form: Comes in a tablet form for easy ingestion and precise dosing. 10-Tablet Pack: Packaged in a bottle of 10 tablets, making it suitable for short-term management or as part of a prescribed treatment regimen.
How it works:
VOGLIBITE M 0.3MG helps manage blood sugar levels. Metformin works by decreasing the amount of glucose released into the blood from the liver, while voglibose reversibly inhibits various carbohydrate-digesting enzymes (such as sucrose, maltose, and isomaltase) in the gut. This results in delayed digestion and absorption of glucose into the bloodstream.
Directions for use:
Take VOGLIBITE M 0.3MG TABLET as directed by your physician. Swallow the tablet with a glass of water; do not crush or chew it. Your doctor will determine the appropriate dose and duration based on your age, body weight, and medical condition.
Warning & Precaution:
PREGNANCY VOGLIBITE M 0.3MG TABLET is not recommended for use during pregnancy. Consult your doctor before using it. BREASTFEEDING VOGLIBITE M 0.3MG TABLET is not recommended for breastfeeding women. Consult your doctor before using it. DRIVING AND USING MACHINES VOGLIBITE M 0.3MG TABLET does not directly affect your ability to drive or operate machinery, but it may cause hypoglycemia (low blood sugar). Be aware of symptoms like weakness, dizziness, rapid heartbeat, vision problems, or difficulty concentrating. Do not drive or use machinery if you experience these symptoms. ALCOHOL Consult your doctor before consuming alcohol while taking VOGLIBITE M 0.3MG TABLET, as it may increase the risk of lactic acidosis, dizziness, or drowsiness. KIDNEY VOGLIBITE M 0.3MG TABLET is not recommended for patients with severe kidney disease. Consult your doctor before use. LIVER VOGLIBITE M 0.3MG TABLET is not recommended for patients with liver problems. Consult your doctor before use. ALLERGY Do not use VOGLIBITE M 0.3MG TABLET if you are allergic to Metformin or Voglibose. HEART DISEASE VOGLIBITE M 0.3MG TABLET is not recommended for patients with heart conditions such as recent heart attack, heart failure, cardiogenic shock, or abnormal breathing. Consult your doctor before use. USE IN PEDIATRICS VOGLIBITE M 0.3MG TABLET is generally not recommended for children and adolescents under 18 years due to insufficient safety and effectiveness data. Consult your doctor before use. USE IN GERIATRICS Use VOGLIBITE M 0.3MG TABLET with caution in elderly patients aged 65 and above. Treatment should generally start at a lower dose, and kidney function may need to be monitored more frequently. Consult your doctor before use.
Super Admin
Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since the 1500s
Recent Posts
-
October 18, 2015
-
October 18, 2015
Products
-
275$
-
137.64$